Navigation Links
Manufacture in Biological Technology

Yongye Biotechnology International Receives License to Manufacture Products

BEIJING, June 8 /PRNewswire-Asia-FirstCall/ -- Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB; "Yongye" or the "Company"), a leading developer and distributor of Shengmingsu brand plant and animal nutrient products located in the People's Republic of China (PRC), today anno...

HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1)

MedImmune Plans to Begin Shipping Seasonal Vaccine to Health Care Providers in August GAITHERSBURG, Md., June 1 /PRNewswire/ -- MedImmune announced today that the U.S. Department of Health and Human Services (HHS) has awarded the company a contract to manufacture monovalent (single-strain) l...

Researchers find better way to manufacture fast computer chips

COLUMBUS, Ohio -- Engineers at Ohio State University are developing a technique for mass producing computer chips made from the same material found in pencils. Experts believe that graphene -- the sheet-like form of carbon found in graphite pencils -- holds the key to smaller, faster electronic...

PolyOrg, Inc. Acquires a License to Manufacture and Distribute PNA Monomers Worldwide

LEOMINSTER, Mass., Jan. 14 /PRNewswire/ -- PolyOrg, Inc. a Massachusetts, USA based organization has entered into a non-exclusive license agreement with the Copenhagen Inventor Group that enables PolyOrg to manufacture and distribute PNA monomers worldwide. "We are extremely pleased to ...

NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance

SOPHIA ANTIPOLIS, France, December 2 /PRNewswire-FirstCall/ -- NicOx S.A. (NYSE Euronext Paris: COX) today announced it has signed an agreement with DSM for the commercial manufacture and supply of naproxcinod drug substance (or API, active pharmaceutical ingredient). Naproxcinod is NicOx' lea...

CPC of America Announces Agreement with BC Tech for Manufacture of MedClose(TM) Vascular Closure System

SARASOTA, Fla., Oct. 24 /PRNewswire-FirstCall/ -- CPC of America, Inc. (OTC Bulletin Board: CPCF), a company focused on developing therapeutic devices for use in endovascular procedures, announced today that it has entered into a manufacturing agreement with BC Tech. According to the agreement...

NEXCORE Technology Selected to Manufacture New Endoscopic Cryotherapy Device

WALDWICK, N.J., Oct. 6 /PRNewswire/ -- NEXCORE Technology, Inc., a world-class original equipment manufacturer (OEM) of medical devices, has reached an agreement with GI Supply of Camp Hill, Pa, for NEXCORE to manufacture GI Supply's revolutionary Polar Wand. Polar Wand is a portable device th...

NicOx Signs Agreement With Capsugel for the Commercial Manufacture of Naproxcinod Oral Capsules

SOPHIA ANTIPOLIS, France, September 23 /PRNewswire-FirstCall/ -- NicOx S.A. (Euronext Paris: COX) today announced it has signed an exclusive agreement with Capsugel, the leading producer of two-piece capsules, for the commercial manufacturing and global supply of naproxcinod capsules. Naproxci...

BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC

Product Line Extension Builds on Existing Brand Strength and Pediatric Focus PLYMOUTH MEETING, Pa., Aug. 18 /Xinhua-PRNewswire-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP; "BMP Sunstone"; the ''Company'') today announced that the Sunstone (Tangshan) Ph...

DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody

PARSIPPANY, N.J., Aug. 12 /PRNewswire/ -- DSM Biologics and MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime Standard Segment, TecDAX) today announced the signing of a Biopharmaceutical Manufacturing Agreement covering process development and cGMP manufacturing of MOR202. MOR202 is a fully h...

SACHEM Launches New Products for High Purity Advanced Ceramic Powders : Avanta AC™ Advanced Ceramics Solutions Offer Unique Advantages over Inorganic Bases in the Manufacture of Advanced Ceramic Nanoparticles

SACHEM has published a white paper titled “Avanta AC™ Advanced Ceramics Solutions as Enablers for Advanced Ceramic Nanopowders” online. This white paper outlines the challenges in manufacturing high-purity ceramic powders on a nanometer scale, as well as the advantages of SACHEM...

Ranbaxy Gains Tentative Approval to Manufacture and Market Valganciclovir Hydrochloride Tablets

'First-to-File' Status Will Provide 180-Day Marketing Exclusivity Upon Final Approval PRINCETON, N.J., June 25 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL), announced today that the company has received tentative approval from the U.S. Food and Drug Administr...

SACHEM Launches New Products for High Purity Advanced Ceramic Powders : Avanta AC™ Advanced Ceramics Solutions Offer Unique Advantages over Inorganic Bases in the Manufacture of Advanced Ceramic Nanoparticles

SACHEM has published a white paper titled “Avanta AC™ Advanced Ceramics Solutions as Enablers for Advanced Ceramic Nanopowders” online. This white paper outlines the challenges in manufacturing high-purity ceramic powders on a nanometer scale, as well as the advantages of SACHEM...

SynCo Bio Partners Completes Manufacture and Release of ActoGeniX' Lead Product for Phase II Clinical Trials

AMSTERDAM, May 14 /PRNewswire/ -- SynCo Bio Partners B.V., a leading GMP biopharmaceutical manufacturer, announced today that it has completed the manufacture and release of ActoGeniX' drug substance AG011 for use in a Phase II clinical trial with ulcerative colitis patients. ActoGeniX is fo...

NicOx Signs Agreement for the Commercial Manufacture of Naproxcinod Drug Substance

SOPHIA ANTIPOLIS, France, March 19 /PRNewswire/ -- NicOx S.A. (Euronext Paris: COX) today announced it has signed an agreement with the fine chemical company Archimica, for the commercial manufacturing and supply of naproxcinod drug substance (or active pharmaceutical ingredient, API). Naproxc...

Ranbaxy Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules

PRINCETON, N.J., Feb. 7 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received tentative approval from the U.S. Food and Drug Administration for Esomeprazole Magnesium Delayed-Release Capsules, ...

Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin

SAN DIEGO, Dec. 18 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today that it entered into strategic cooperation agreements with Siegfried Ltd., an affiliate of Siegfried Holding AG (SWX: SFZN). The agreements primarily relate to the manufacturing of lorcase...

GeoPharma, Inc. Receives FDA Approval to Manufacture and Distribute Carprofen

LARGO, Fla., Nov. 12 /PRNewswire-FirstCall/ -- GeoPharma, Inc. (Nasdaq: GORX) (the "Company") GeoPharma, Inc. announced today it has received an approval from the FDA to begin producing Carprofen. Commonly marketed by Pfizer as Rimadyl(TM), Carprofen is a non-steroidal anti-inflammatory drug ...

CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products

KIRKLAND, Wash., Sept. 19 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (the "Company") (OTC Bulletin Board: CCYG) has formed a new Device Division in order to develop, manufacture and market its patented line of stem cell cultivation and replication devices. CellCyte Genetics is de...

Frost & Sullivan Recognizes Kraton Polymers for Developing a New Generation of Polymer Grades Suitable for High-Speed Processing in Nonwoven Manufacture

MOUNTAIN VIEW, Calif., March 31 /PRNewswire/ -- Based on its recent analysis of the elastic nonwovens market, Frost & Sullivan recognizes Kraton Polymers LLC with the 2009 North American Frost & Sullivan Technology Leadership of the Year Award for its on-going measures to lead innovation i...

Microparts interest group workshop

... Recent advances in modern manufacturing techniques has made it possible to manufacture small and complex components to extremely high accuracies. In direct response to the extreme demands of quality assurance for the measurement of size,...

Novavax Reports Second Quarter 2009 Financial Results

...k through the ATM program. Launched CPL Biologicals Pvt. Ltd, the previously announced joint venture with Cadila Pharmaceuticals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. Recruited key executives to support the future growth of the company. New appointme...

AOBO Announces New Product Launch

...armaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter...armaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter...

American Oriental Bioengineering Reports Second Quarter 2009 Financial Results

...armaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter...armaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter...

Synthetech Reports First Quarter Fiscal 2010 Results

...in organic synthesis, biocatalysis and chiral technologies. We develop and manufacture amino acid derivatives, specialty amino acids, peptide fragments and propri...ministration ( FDA ) regulations. Our products support the development and manufacture of therapeutic peptides and peptidomimetic (peptide-like) small molecule dr...

Exciton Technologies receives FDA approval to market exSALT(TM)

... uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the ability to economically manufacture its products, the potential of its products, the success and timely completion of clinical studies and trials, the Company's ability to successfully c...

GeoVax Labs, Inc. Provides Clinical Studies Update

...ially from those described in the forward-looking statements. Risks and uncertainties include, but are not limited to, whether: GeoVax can develop and manufacture these vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively p...

ImmunoVaccine Technologies Partners With Scancell to Advance DNA Vaccine Delivery

...ed David Evans, chairman of Scancell. DNA-based vaccines have gained popularity due to promising results reported the clinic, their relative ease of manufacture and potential for enhanced stability. There is currently a need for simple alternative methods of delivering DNA vaccines DepoVax(TM) is a vaccine-e...

Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results

...ents with non-BI (NAP1/027) strains. The United States Patent and Trademark Office issued Optimer a production patent covering steps used in the manufacture of fidaxomicin. About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discover...

ETC Biomedical Announces Chamber Sale in India

... ETC was incorporated in 1969 in Pennsylvania and this year we will celebrate our 40th anniversary. Our core technologies include the design, manufacture and sale of Training Services (TSG) which includes (1) software driven products and services used to create and monitor the physiological effects of f...

Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials

...al government. About Sinovac Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's commercialized vaccines include Healive(R) (hepatitis A),...

Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials

... of July 2009. About Sinovac Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's commercialized vaccines include Healive(R) (hepatitis A), ...

Cardinal Health Completes Biotech Acquisition

...es 26 cyclotron-based PET radiopharmaceutical manufacturing facilities. These facilities are registered with the Food and Drug Administration (FDA) to manufacture PET imaging agents that are used by physicians to diagnose various medical conditions. With the addition of Biotech's four nuclear pharmacies...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

...or Intermezzo ((R)), if approved; unforeseen expenses related to FDA approval and the business of Transcept generally; dependence on third parties to manufacture Intermezzo ((R)); a decision by Purdue to not devote sufficient time or resources to commercialization of Intermezzo ((R)); obtaining, maintaining a...

Cornerstone Therapeutics Announces Closing of Chiesi Transaction

...sary sales, marketing, supply chain, distribution and manufacturing capabilities to commercialize our products, including difficulties relating to the manufacture of Zyflo((R)) CR tablets; the possibility that the Food and Drug Administration (the FDA) will take enforcement action against us or one or more of ou...

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

...tual property; government regulation of the pharmaceutical industry; our dependence on a small number of products and on outside manufacturers for the manufacture of our products; our dependence on third parties to supply raw materials and to provide services for certain core aspects of our business; new regulat...

Eli Lilly & Company and ScinoPharm Taiwan Ltd. Announce Settlement of Gemcitabine Litigation

...l ongoing patent litigations between the companies relating to ScinoPharm's manufacture and sale of gemcitabine hydrochloride around the world. As part of the settlement, Lilly has granted ScinoPharm a royalty bearing license to manufacture and sell gemcitabine hydrochloride (API) throughout the world, excluding on...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

... were more than offset by higher volumes and new products. Specialty, consisting of Mylan's Dey business, which focuses on the development, manufacture and marketing of specialty pharmaceuticals in the respiratory and severe allergy markets, reported third-party sales of $122.8 million, an increase of...

Patent Awarded for a New X-ray Imaging Technology with Capability Unrealized with Present Day Radiological Modalities

...atented, award-winning innovations in x-ray imaging have been used worldwide in the electronics assembly industry, in security applications and in the manufacture of life-saving medical devices. For more information, contact Gil Zweig at 973-361-8866 or gzweig(at)glenbrooktech.com. ### Read the full sto...

Microban Partners With YogaDirect.com to Launch Yoga Mats With Zinc Antimicrobial Technology

..., including regulatory and marketing support. The Microban(R) brand promises continuous and durable antimicrobial product protection, built-in during manufacture to not wear out for the useful life of the product. Microban International is headquartered in North Carolina with operations in North America, Europ...
Other Tags
(Date:4/20/2014)... demonstrate a bizarre property never before seen at a ... scientists at the University of Cambridge. The property ... application as wide-ranging as soundproofing, super-absorbent sponges and bulletproof ... if one pulls on an elastic band, the elastic ... squeeze a material and it will expand for ...
(Date:4/20/2014)... used to treat lung, breast and pancreatic cancers also ... the University of California, San Diego School of Medicine ... the surface of drug-resistant tumors that appears responsible for ... of cancer cells. , The findings, published in ... Cell Biology , may point to new therapeutic opportunities ...
(Date:4/20/2014)... with Down syndrome have a heightened risk of developing ... able to explain why. Now, a team of ... the two conditions. , In a study posted online ... researchers track the genetic chain of events that links ... havoc that occurs in ALL. Their findings are ...
Breaking Biology News(10 mins):Bulletproof nuclei? Stem cells exhibit unusual absorption property 2Cancer stem cells linked to drug resistance 2Dana-Farber researchers uncover link between Down syndrome and leukemia 2Dana-Farber researchers uncover link between Down syndrome and leukemia 3
(Date:4/18/2014)... in French . ... and regenerative medicine. A team led by Ludwik Leibler ... Tech) and Didier Letourneur from the Laboratoire Recherche Vasculaire ... demonstrated that the principle of adhesion by aqueous solutions ... soft-tissue organs and tissues. This easy-to-use gluing method has ...
(Date:4/17/2014)... genetic variant specifically associated with the risk of ... per cent of all breast cancer cases. , ... sub-type, called invasive lobular carcinoma, gives researchers important ... kind of breast cancer, which can be missed ... in the journal PloS Genetics , was ...
(Date:4/17/2014)... the April issue of Experimental Biology and ... Drs. Rex Gaskins and Paul Kenis in the ... of the University of Illinois Urbana-Champaign describe their ... reactions underlie a variety of cell functions including ... these crucial roles in regulating normal cellular behavior, ...
(Date:4/17/2014)... Bonheur Children,s Hospital Pediatrician-in-Chief Jon McCullers, MD, was ... April issue of Nature Reviews Microbiology , ... Dr. McCullers, a world-renowned infectious disease specialist, and ... University of Tennessee Health Science Center, analyzed the ... 1957 and 1968 pandemics, as well as more ...
(Date:4/17/2014)... that as many as 10 million older Americans suffer ... and isolation. , However, new research a project ... Americans for six years found that Internet use ... by more than 30 percent. , "That,s a very ... professor of telecommunication, information studies and media who led ...
Breaking Medicine News(10 mins):Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Internet use can help ward off depression among elderly 2
Other Contents